Glarine Biopen 100IU/ml SC Injection is indicated to improve glycemic control in adults and children with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus.
🛒 How to order this item?
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
Insulin Glargine is utilized to manage diabetes in both children and adults. As a long-acting insulin, it maintains consistent blood sugar control for hours after injection, ensuring effective management throughout the day.
Hypoglycemia (low blood sugar) is a possible side effect of Insulin Glargine, leading to sensations like hunger, irritability, dizziness, anxiety, or shakiness. Swiftly consume a quick-acting sugar source (such as fruit juice, candy, or raisins) to address these symptoms. If symptoms persist or worsen, consult your doctor. Other side effects include weight gain and local reactions at the injection site, like redness, itching, swelling, or skin thickening. Alcohol consumption can also lower blood sugar levels, so it's best to avoid it.
Follow your doctor's instructions precisely when using Insulin Glargine. Administer it subcutaneously (under the skin) at the same time daily to maintain consistent levels in your body. Don't skip doses or discontinue treatment without consulting your doctor, as this could lead to elevated blood sugar levels. Combining proper diet and regular exercise with medication yields optimal results.
If you're allergic to Insulin Glargine, don't use it. Inform your doctor about liver or kidney issues. Children under 6 years old should not use this medication. If you're pregnant, planning pregnancy, or breastfeeding, only take this medicine if prescribed by your doctor.
Refrain from alcohol consumption while using Glarine Biopen 100IU/ml SC Injection, as it can lead to fluctuations in your blood sugar levels.
If you are pregnant, suspect pregnancy, or plan to conceive, consult your doctor before using Glarine Biopen 100IU/ml SC Injection. Maintaining careful control of your diabetes, especially to prevent hypoglycemia, is crucial for the well-being of both you and your baby. Your doctor will adjust your dose accordingly.
Notify your doctor if you are breastfeeding before using Glarine Biopen 100IU/ml SC Injection, as its excretion in breast milk is not established. Your doctor will make necessary adjustments to your dose and diet.
Avoid driving or operating machinery while using Biopen 100IU/ml SC Injection, as your blood sugar levels can vary, affecting your concentration and reaction time. If you experience frequent episodes of hypoglycemia, consult your doctor.
Exercise caution when using Glarine Biopen 100IU/ml SC Injection if you have kidney disease. Your dose will be tailored to your age, body weight, and disease status. Prior consultation with your doctor is advisable.
Approach the use of Glarine Biopen 100IU/ml SC Injection cautiously if you have liver disease. Your dose will be adjusted based on your age, body weight, and disease condition. Consult your doctor before starting this medication.
Glarine Biopen 100IU/ml SC Injection is employed to manage both Type 1 Diabetes mellitus and Type 2 Diabetes Mellitus:
Insulin Glargine is a sterile solution of insulin glargine for use as a subcutaneous injection. Insulin glargine is a recombinant human insulin analog that is a long-acting (up to the 24-hour duration of action), parenteral blood glucose lowering agent. Insulin Glargine is produced by recombinant DNA technology. The primary function of insulin glargine is the regulation of glucose metabolism. Insulin and its analogs lower blood glucose by stimulating peripheral glucose uptake, primarily by skeletal muscle and fat, and by inhibiting hepatic glucose production. Insulin inhibits lipolysis and proteolysis and enhances protein synthesis.
Insulin Glargine, a prolonged-acting analog of human insulin, provides consistent glucose regulation over 24 hours, allowing for once-daily dosing. It has a potency similar to human insulin.
Dosage and Administration:
Glarine Biopen 100IU/ml SC Injection is administered by healthcare professionals based on individual factors such as age, body weight, and medical condition.
Several drugs can impact glucose metabolism, potentially necessitating dose adjustments for both Insulin and Insulin glargine.
Substances that may decrease Insulin and Insulin glargine requirements:
Substances that may increase Insulin and Insulin glargine requirements:
Interaction Note:
Insulin glargine is contraindicated in patients with hypersensitivity to insulin glargine or any of its excipients
Pregnancy Category C. Insulin glargine should only be utilized during pregnancy if the possible benefits outweigh the potential risks to the developing fetus.
Lactation: The presence of insulin glargine in human milk remains uncertain. As various drugs, including human insulin, can be found in breast milk, cautious administration of insulin glargine to nursing mothers is advised. Lactating women might need adjustments in both insulin dosage and dietary intake.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.